Probiotic effect of Bacillus spp. isolated from African nightcrawler (Eudrilus eugeniae) on the performance of Nile Tilapia (Oreochromis niloticus L.).

This study evaluated the effects of the probiotic Bacillus spp. isolated from African nightcrawler (Eudrilus eugeniae) on the growth and survival performances of Nile tilapia (Oreochromis niloticus). A total of 400 Nile tilapia fingerlings (1.76 ± 0.07 g) were equally and randomly distributed into 20 glass aquaria and divided into five experimental groups with four replicates. Each experimental group was fed with a commercial diet (control) supplemented (at 108 CFU·g-1) with one of the four Bacillus spp. (ANSCI9, BFAR9, RM3, and RM10) at five percent of their body weight. After 30 days of feeding, the surviving fish were challenged with Aeromonas hydrophila to observe their survival. The treatment groups supplemented with BFAR9 (2.73 ± 0.26 g) and RM10 (3.15 ± 0.30 g) showed significantly higher (P < 0.05) absolute growth than the control (2.20 ± 0.16 g) group. Furthermore, those given with RM10 had better (P < 0.05) specific growth rate (SGR) (1.60 ± 0.10%·day-1) relative growth rate (RGR) (181.39 ± 18.16%) and feed conversion ratio (FCR) (1.99 ± 0.13) compared to the control group (SGR = 1.29 ± 0.07%·day-1; RGR = 129.84 ± 9.77%; FCR = 2.60 ± 0.16). The challenge test revealed that all Bacillus spp.-treated groups showed significantly higher (P < 0.05) survival rates (ANSCI9 = 82.5 ± 8.16%; BFAR9 = 80.0 ± 10.00%; RM3 = 77.5 ± 20.82%; RM10 = 85.0 ± 10.00%) than the control group (55.00 ± 19.15%), with the highest relative level of protection recorded for RM10 (66.67%). These results revealed that the probiotic Bacillus spp. isolated from E. eugeniae improved the growth, feed utilization, waste excretion, and the disease resistance of Nile tilapia.